These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30537032)

  • 1. FAM83H-AS1 is associated with clinical progression and modulates cell proliferation, migration, and invasion in bladder cancer.
    Shan H; Yang Y; Zhu X; Han X; Zhang P; Zhang X
    J Cell Biochem; 2019 Mar; 120(3):4687-4693. PubMed ID: 30537032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting roles of long non-coding RNA FAM83H-AS1 in bladder cancer growth, metastasis, and angiogenesis through the c-Myc-mediated ULK3 upregulation.
    Liu B; Gao W; Sun W; Li L; Wang C; Yang X; Liu J; Guo Y
    Cell Cycle; 2020 Dec; 19(24):3546-3562. PubMed ID: 33289601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
    Gong YB; Zou YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer.
    Zhang J; Feng S; Su W; Bai S; Xiao L; Wang L; Thomas DG; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Beer DG; Guo YM; Chen G
    Sci Rep; 2017 Feb; 7():42819. PubMed ID: 28198463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
    Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
    Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Tuo Z; Zhang J; Xue W
    Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA FAM83H-AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer.
    El-Ashmawy NE; Al-Ashmawy GM; Hamouda SM
    Cell Biochem Funct; 2021 Apr; 39(3):350-356. PubMed ID: 33159470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21).
    Bi YY; Shen G; Quan Y; Jiang W; Xu F
    J Cell Physiol; 2018 Nov; 233(11):8896-8907. PubMed ID: 29870057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma.
    Quan LJ; Wang WJ
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31076545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
    El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
    Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis.
    Gao H; Gong N; Ma Z; Miao X; Chen J; Cao Y; Zhang G
    Int J Biol Macromol; 2018 Sep; 116():545-551. PubMed ID: 29753015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1.
    Luo XJ; Lu YX; Wang Y; Huang R; Liu J; Jin Y; Liu ZK; Liu ZX; Huang QT; Pu HY; Zeng ZL; Xu R; Zhao Q; Wu QN
    Cancer Lett; 2024 Aug; 598():217085. PubMed ID: 38964733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.
    Liu N; Zhang C; Zhang L
    Mol Biotechnol; 2024 Aug; 66(8):1883-1893. PubMed ID: 37477820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA FAM83H-AS1 induces nucleus pulposus cell growth via targeting the Notch signaling pathway.
    Wei R; Chen Y; Zhao Z; Gu Q; Wu J
    J Cell Physiol; 2019 Dec; 234(12):22163-22171. PubMed ID: 31102263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA
    Wu D; Zhang T; Wang J; Zhou J; Pan H; Qu P
    Aging (Albany NY); 2019 Dec; 11(24):12624-12640. PubMed ID: 31848324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression
    Liu B; Qian D; Zhou W; Jiang H; Xiang Z; Wu D
    Front Oncol; 2020; 10():620306. PubMed ID: 33614501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA AFAP1-AS1 promotes proliferation and invasion in prostate cancer via targeting miR-512-3p.
    Wang K; Sun H; Sun T; Qu H; Xie Q; Lv H; Hu B
    Gene; 2020 Feb; 726():144169. PubMed ID: 31669642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.